Fenebrutinib
| CAS No. | 1434048-34-6 |
|---|---|
| MDL No. | N/A |
| MF | C37H44N8O4 |
| MW | 664.80 |
| InChI Key | WNEODWDFDXWOLU-QHCPKHFHSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Fenebrutinib is an orally available BTK inhibitor with antineoplastic potential. It inhibits BTK activity and blocks the activation of the B-cell antigen receptor (BCR) signaling pathway.
| CAS No. | 1434048-34-6 |
|---|---|
| Product Name | Fenebrutinib |
Biological Targets
BTK
Associated Conditions
multiple sclerosis·chronic progressive multiple sclerosis·urticaria·type II hypersensitivity reaction disease·systemic lupus erythematosus·
* The information provided here is compiled from public sources and is for reference only.
